UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:September 01,
Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tenax Therapeutics Charts.
Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tenax Therapeutics Charts.

Tenax Therapeutics, Inc. News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 May 2024 (6 days ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 14 May 2024 (6 days ago) • Edgar (US Regulatory)
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Tuesday 14 May 2024 (6 days ago) • GlobeNewswire Inc.
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Tuesday 30 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
Tuesday 9 April 2024 (1 month ago) • GlobeNewswire Inc.
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
Thursday 28 March 2024 (2 months ago) • GlobeNewswire Inc.
Tenax Therapeutics to Present at the 36th Annual Roth Conference
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Thursday 29 February 2024 (3 months ago) • GlobeNewswire Inc.
Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Tuesday 20 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 20 February 2024 (3 months ago) • Edgar (US Regulatory)

More Tenax Therapeutics, Inc. News Articles